Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer

NCT00640471 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: brivanib alaninate

Sponsor

NCIC Clinical Trials Group